Stifel Financial
BBP icon

Stifel Financial’s Virtus Biotech ETF BBP Stock Holding History

Stifel Financial’s Portfolio BBP Stock Details BBP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-4,155
Closed -$219K – 3290
2023
Q2 		$219K Sell
4,155
-252
-6% -$13.2K ﹤0.01% 2995
2023
Q1 		$217K Sell
4,407
-1,353
-23% -$67.9K ﹤0.01% 3006
2022
Q4 		$284K Sell
5,760
-100
-2% -$4.79K ﹤0.01% 2793
2022
Q3 		$266K Buy
+5,860
New +$271K ﹤0.01% 2798
2021
Q4 		– Sell
-7,644
Closed -$389K – 3374
2021
Q3 		$389K Sell
7,644
-100
-1% -$5.16K ﹤0.01% 2727
2021
Q2 		$413K Sell
7,744
-495
-6% -$26.1K ﹤0.01% 2694
2021
Q1 		$431K Buy
8,239
+135
+2% +$7.53K ﹤0.01% 2573
2020
Q4 		$431K Buy
8,104
+357
+5% +$18.3K ﹤0.01% 2410
2020
Q3 		$369K Buy
7,747
+209
+3% +$9.73K ﹤0.01% 2273
2020
Q2 		$357K Sell
7,538
-89
-1% -$3.98K ﹤0.01% 2241
2020
Q1 		$288K Sell
7,627
-100
-1% -$4.13K ﹤0.01% 2209
2019
Q4 		$326K Sell
7,727
-826
-10% -$33.2K ﹤0.01% 2496
2019
Q3 		$317K Sell
8,553
-1,305
-13% -$50K ﹤0.01% 2417
2019
Q2 		$397K Buy
9,858
+2
+0% +$82 ﹤0.01% 2327
2019
Q1 		$425K Sell
9,856
-3,568
-27% -$150K ﹤0.01% 2161
2018
Q4 		$467K Sell
13,424
-1,578
-11% -$60K ﹤0.01% 1967
2018
Q3 		$676K Sell
15,002
-16
-0.1% -$715 ﹤0.01% 1930
2018
Q2 		$646K Buy
15,018
+250
+2% +$10.6K ﹤0.01% 1884
2018
Q1 		$599K Buy
14,768
+1,570
+12% +$66.1K ﹤0.01% 1863
2017
Q4 		$529K Buy
13,198
+2,893
+28% +$115K ﹤0.01% 1881
2017
Q3 		$422K Buy
10,305
+2,090
+25% +$83.6K ﹤0.01% 1984
2017
Q2 		$328K Buy
8,215
+2,390
+41% +$89.3K ﹤0.01% 2085
2017
Q1 		$223K Buy
+5,825
New +$213K ﹤0.01% 2266
2016
Q4 		– Sell
-18,335
Closed -$611K – 2469
2016
Q3 		$611K Buy
18,335
+7,650
+72% +$236K ﹤0.01% 1612
2016
Q2 		$288K Buy
+10,685
New +$282K ﹤0.01% 2057

Other funds holding BBP

Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
Carson Wealth (CWM LLC)
Carson Wealth (CWM LLC) Omaha, Nebraska $38.1B AUM 19.66% 1-Year Est. Return
DSC
Duncker Streett & Co St. Louis, Missouri $526M AUM 22.2% 1-Year Est. Return
FWM
Focused Wealth Management Newburgh, New York $964M AUM 18.71% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
GEA
Glen Eagle Advisors Kingston, New Jersey $714M AUM 18.87% 1-Year Est. Return

Stifel Financial's BBP Position: Q3 2023 in Review

Stifel Financial sold out of Virtus Biotech ETF (BBP) in Q3 2023, closing a stake of 4,155 shares — an estimated $219K sold.

Stifel Financial first reported a position in BBP in Q2 2016 and held it in 25 quarters. The position peaked at $676K in Q3 2018. 11 funds tracked by Wall St. Rank hold BBP as of Q3 2023.

  • Stifel Financial reported no remaining Virtus Biotech ETF position as of Q3 2023 after selling out during the quarter.
  • Stifel Financial sold 4,155 Virtus Biotech ETF shares in Q3 2023, an estimated $219K.
  • Stifel Financial first reported a position in Virtus Biotech ETF in Q2 2016 and held it in 25 quarters.
  • Stifel Financial's Virtus Biotech ETF position peaked at $676K in Q3 2018.
  • 11 funds tracked by Wall St. Rank held Virtus Biotech ETF as of Q3 2023.

Based on Stifel Financial's 13F filing for Q3 2023, filed 13 Nov 2023.